مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

792
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

EVALUATION OF CLOFIBRATE IN THE TREATMENT OF NON-HEMOLITIC INDIRECT HYPER BILIRUBINEMIA IN TERM INFANTS

Pages

  1079-1083

Abstract

 Background: HYPERBILIRUBINEMIA is a common problem in NEONATEs but sever HYPERBILIRUBINEMIA will cause kernicterus. The aim of this study is to evaluate the efficacy of oral CLOFIBRATE in treatment of indirect HYPERBILIRUBINEMIAin non hemolytic jaundiced full term NEONATEs.Materials and Methods: In one clinical trial study were evaluated 60 healthy full term NEONATEs with nonhemolyticjaundice. 30 NEONATEs (control group) received only phototraphy while the other 30 NEONATEs treated with single oral doses of CLOFIBRATE (100mg/kg) with phototraphy. Two groups were compared by the mean plasma total and indirect bilirubin after treatment and duration of hospitalization and need for exchange transfusion.Results: Total and indirect bilirubin levels after treatment showed that decreasing amount of total and indirect bilirubin within time in CLOFIBRATE - treated group significantly is more than control group. also the average duration of hospitalization and need for phototraphy on CLOFIBRATE - treated group is lower than control group. In the studied NEONATEs with a single dose of CLOFIBRATE no side effects were observed during hospitalization and after discharge.Conclusion: up to now many pharmacological agent have been used for prevention or treatment of neonatal jaundice. Drugs such as Phenobarbital, Activated charcol and plain agar and metalloporphyrins have been used for this purpose but None of this drugs has been accepted completely by efficacy and safety and not available for routine use. CLOFIBRATE due to its ideal efficacy in decreasing bilirubin and duration of hospitalization and oral easy use and availability of this drug is considered to be suitable treatment way for neonatalnonhemolytic jaundice.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    EGHBALIAN, F., & POURHOSSEIN, A.A.F.. (2007). EVALUATION OF CLOFIBRATE IN THE TREATMENT OF NON-HEMOLITIC INDIRECT HYPER BILIRUBINEMIA IN TERM INFANTS. ANNALS OF MILITARY AND HEALTH SCIENCES RESEARCH, 5(1 (SERIAL NUMBER 17)), 1079-1083. SID. https://sid.ir/paper/96494/en

    Vancouver: Copy

    EGHBALIAN F., POURHOSSEIN A.A.F.. EVALUATION OF CLOFIBRATE IN THE TREATMENT OF NON-HEMOLITIC INDIRECT HYPER BILIRUBINEMIA IN TERM INFANTS. ANNALS OF MILITARY AND HEALTH SCIENCES RESEARCH[Internet]. 2007;5(1 (SERIAL NUMBER 17)):1079-1083. Available from: https://sid.ir/paper/96494/en

    IEEE: Copy

    F. EGHBALIAN, and A.A.F. POURHOSSEIN, “EVALUATION OF CLOFIBRATE IN THE TREATMENT OF NON-HEMOLITIC INDIRECT HYPER BILIRUBINEMIA IN TERM INFANTS,” ANNALS OF MILITARY AND HEALTH SCIENCES RESEARCH, vol. 5, no. 1 (SERIAL NUMBER 17), pp. 1079–1083, 2007, [Online]. Available: https://sid.ir/paper/96494/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top